Abstract
PURPOSE: Improved survival in CF has been seen with aggressive antibiotic usage. However, identification of new bacteria and fungi from sputa of CF patients is increasingly being reported. The clinical implications of these isolates remain unknown. Recently, Exophiala (Wangiella) dermatitidis (Ed), has been identified in sputum of cystic fibrosis (CF) patients. The purpose of this study was to report our recent experience of this pathogen and determine any clinical significance in CF patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
